BSEINDRAYANI BIOTECH LTD.· Agricultural Food & other ProductsHighNeutral
Announced Wed, 7 Oct, 2026 · 18:08 IST

Q1 FY27: Consolidated PAT up 245%, Standalone revenue down 38%

Revenue DeclineRevenue Growth 20pctPat Growth 25pctResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.1%Reaction day
₹10.09
prior close
₹10.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-2.8%-2.3% vs market
Other Agricultural Products peers, median of 59sector-1.6%-3.5% vs sector

On the reaction day the stock moved 2.3 pts less than Nifty Microcap 250 and 3.5 pts less than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
-3.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.1-2.8-2.3-1.6-3.5
Next day
-9.5-2.5-7.0-1.3-8.2
2d
-13.1-1.7-11.4-1.1-12.0
3d
-15.8-1.5-14.3-1.1-14.7
4d
-14.1-0.8-13.3-0.2-13.9
5d
-19.2-2.4-16.8-1.1-18.1
1w
-18.0-3.4-14.7-3.0-15.0
15d
-20.2pendingpending-7.4-12.8
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Other Agricultural Products peers, median of 59Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Consolidated revenue grew 29.6% YoY to Rs 3,770.55 lakh with PAT jumping 245% to Rs 54 lakh (EPS Rs 0.06). Standalone revenue, however, fell 37.9% YoY to Rs 415.34 lakh though standalone PAT rose 13.5% to Rs 14.50 lakh. Total consolidated income stood at Rs 3,929.65 lakh. Auditors Venkatesh & Co gave an unmodified opinion. Results cover 7 subsidiaries and 2 step-down subsidiaries. Board also reconstituted Audit, Stakeholder Relationship, and Rights Issue Committees.

Likely market impact

Mixed picture: strong subsidiary-driven consolidated growth offsets weak standalone performance. Watch standalone recovery in coming quarters.